Intravenous infusion of prostaglandin E1 therapy in extremity ischemia
Prostaglandins are potent vasoactive agents with wide variety of other actions - vasodilatation, fibrinolysis and inhibition of platelet aggregation. PGE1 was the agent used since 1973 for cardiovascular diseases, mainly in patients with advanced PVD. PGE1 intra venous infusion has shown to be benef...
Main Author: | Pinjala Ramakrishna |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Vascular and Endovascular Surgery |
Subjects: | |
Online Access: | http://www.indjvascsurg.org/article.asp?issn=0972-0820;year=2017;volume=4;issue=2;spage=38;epage=42;aulast=Ramakrishna |
Similar Items
-
Efficacy of prostaglandin E1 as adjuvant therapy for mild to moderate acute pancreatitis
by: JI Bai, et al.
Published: (2016-01-01) -
Protective Effects of N-acetylcysteine and a Prostaglandin E1 Analog, Alprostadil, Against Hepatic Ischemia: Reperfusion Injury in Rats
by: Cheng-Chu Hsieh, et al.
Published: (2014-01-01) -
Cardiac effects of prostaglandins E₁ and F₁α
by: Vadlamudi, Rao Venkata Satya Veerabhadra
Published: (2010) -
Ischemic preconditioning vs adenosine vs prostaglandin E1 for protection against liver ischemia/reperfusion injury
by: M. Radojkovic, et al. -
The total synthesis of prostaglandin.
by: Simonovitch, Chiam.
Published: (1967)